tradingkey.logo

Globus Medical Inc

GMED
87.000USD
+0.120+0.14%
Close 12/19, 16:00ETQuotes delayed by 15 min
11.71BMarket Cap
27.83P/E TTM

Globus Medical Inc

87.000
+0.120+0.14%

More Details of Globus Medical Inc Company

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

Globus Medical Inc Info

Ticker SymbolGMED
Company nameGlobus Medical Inc
IPO dateMar 08, 2012
CEOPfeil (Keith W)
Number of employees5300
Security typeOrdinary Share
Fiscal year-endMar 08
Address2560 General Armistead Ave
CityAUDUBON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19403
Phone16109301800
Websitehttps://www.globusmedical.com/
Ticker SymbolGMED
IPO dateMar 08, 2012
CEOPfeil (Keith W)

Company Executives of Globus Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
--
Mr. David C. Paul
Mr. David C. Paul
Executive Chairman of the Board
Executive Chairman of the Board
34.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
15.38K
-39.39%
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Mr. Stephen T. (Steve) Zarrilli
Mr. Stephen T. (Steve) Zarrilli
Independent Director
Independent Director
--
--
Mr. James R. Tobin
Mr. James R. Tobin
Independent Director
Independent Director
--
--
Ms. Kelly Grace Huller, J.D.
Ms. Kelly Grace Huller, J.D.
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
--
Mr. David C. Paul
Mr. David C. Paul
Executive Chairman of the Board
Executive Chairman of the Board
34.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
15.38K
-39.39%
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Musculoskeletal Solutions
710.18M
95.28%
Enabling Technologies
35.16M
4.72%
By RegionUSD
Name
Revenue
Proportion
United States
600.78M
80.61%
International
144.56M
19.39%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Musculoskeletal Solutions
710.18M
95.28%
Enabling Technologies
35.16M
4.72%

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.50%
BlackRock Institutional Trust Company, N.A.
8.68%
Janus Henderson Investors
6.78%
Sculptor Capital Management, Inc
3.14%
State Street Investment Management (US)
3.11%
Other
68.79%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.50%
BlackRock Institutional Trust Company, N.A.
8.68%
Janus Henderson Investors
6.78%
Sculptor Capital Management, Inc
3.14%
State Street Investment Management (US)
3.11%
Other
68.79%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.22%
Investment Advisor/Hedge Fund
36.39%
Hedge Fund
12.27%
Research Firm
2.10%
Pension Fund
1.92%
Sovereign Wealth Fund
1.09%
Bank and Trust
0.76%
Individual Investor
0.71%
Venture Capital
0.39%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1029
117.81M
104.61%
-7.42M
2025Q2
1034
115.30M
102.09%
-12.49M
2025Q1
1057
115.54M
102.35%
-11.15M
2024Q4
1031
113.94M
83.15%
-12.71M
2024Q3
978
112.33M
98.84%
-21.04M
2024Q2
969
117.21M
103.71%
-15.66M
2024Q1
950
117.87M
104.30%
-9.50M
2023Q4
917
111.19M
96.81%
-13.25M
2023Q3
911
113.44M
96.67%
+12.22M
2023Q2
864
84.90M
108.73%
-4.84M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
10.68M
9.49%
-200.59K
-1.84%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.81M
8.71%
-54.44K
-0.55%
Jun 30, 2025
Janus Henderson Investors
8.21M
7.29%
+1.20M
+17.14%
Jun 30, 2025
Sculptor Capital Management, Inc
2.76M
2.45%
+667.85K
+31.91%
Jun 30, 2025
State Street Investment Management (US)
3.47M
3.08%
-142.15K
-3.93%
Jun 30, 2025
Burgundy Asset Management Ltd.
3.48M
3.09%
+679.69K
+24.26%
Jun 30, 2025
JP Morgan Asset Management
3.15M
2.8%
+707.91K
+28.93%
Jun 30, 2025
William Blair Investment Management, LLC
2.41M
2.14%
+131.24K
+5.77%
Jun 30, 2025
Madison Avenue Partners LP
1.71M
1.52%
+1.71M
--
Jun 30, 2025
Geneva Capital Management LLC
2.08M
1.85%
+249.14K
+13.59%
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
2.96%
First Trust Indxx Medical Devices ETF
2.14%
First Trust Health Care Alphadex Fund
1.84%
State Street SPDR S&P Health Care Equipment ETF
1.84%
ROBO Global Healthcare Technology & Innovation ETF
1.33%
Invesco S&P MidCap 400 Pure Growth ETF
1.32%
ROBO Global Robotics and Automation Index ETF
1.2%
Global X Guru Index ETF
1.2%
ALPS Disruptive Technologies ETF
0.99%
Pacer US Cash Cows Growth ETF
0.97%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion2.96%
First Trust Indxx Medical Devices ETF
Proportion2.14%
First Trust Health Care Alphadex Fund
Proportion1.84%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.84%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.33%
Invesco S&P MidCap 400 Pure Growth ETF
Proportion1.32%
ROBO Global Robotics and Automation Index ETF
Proportion1.2%
Global X Guru Index ETF
Proportion1.2%
ALPS Disruptive Technologies ETF
Proportion0.99%
Pacer US Cash Cows Growth ETF
Proportion0.97%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of Globus Medical Inc?

The top five shareholders of Globus Medical Inc are:
The Vanguard Group, Inc. holds 10.68M shares, accounting for 9.49% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 9.81M shares, accounting for 8.71% of the total shares.
Janus Henderson Investors holds 8.21M shares, accounting for 7.29% of the total shares.
Sculptor Capital Management, Inc holds 2.76M shares, accounting for 2.45% of the total shares.
State Street Investment Management (US) holds 3.47M shares, accounting for 3.08% of the total shares.

What are the top three shareholder types of Globus Medical Inc?

The top three shareholder types of Globus Medical Inc are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Janus Henderson Investors

How many institutions hold shares of Globus Medical Inc (GMED)?

As of 2025Q3, 1029 institutions hold shares of Globus Medical Inc, with a combined market value of approximately 117.81M, accounting for 104.61% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 2.52%.

What is the biggest source of revenue for Globus Medical Inc?

In FY2025Q2, the Musculoskeletal Solutions business generated the highest revenue for Globus Medical Inc, amounting to 710.18M and accounting for 95.28% of total revenue.
KeyAI